Clinical Trials Logo

Clinical Trial Details — Status: Recruiting

Administrative data

NCT number NCT01589536
Other study ID # 10001
Secondary ID
Status Recruiting
Phase N/A
First received March 2, 2012
Last updated May 1, 2012
Start date October 2011
Est. completion date December 2016

Study information

Verified date April 2012
Source Clinic Roderbirken
Contact n/a
Is FDA regulated No
Health authority Germany: Ethics Commission
Study type Interventional

Clinical Trial Summary

The purpose of the study is to verfiy the hypothesis if a short intensive psychocardiological interval-intervention, combined with a structured follow up, decreases the rate of disability retirements caused by psychosocial co-morbidity of patients with coronary heart disease.


Description:

The purpose of the study is to verfiy the hypothesis if a short intensive psychocardiological interval intervention, combined with a structured follow up, decreases the rate of disability retirements caused by psychosocial co-morbidity of patients with coronary heart disease.


Recruitment information / eligibility

Status Recruiting
Enrollment 480
Est. completion date December 2016
Est. primary completion date December 2015
Accepts healthy volunteers No
Gender Both
Age group 18 Years to 58 Years
Eligibility Inclusion Criteria:

- Coronary heart disease

- Disease-related psychosocial morbidity

- not a disability retirements

- Insured with the German Rheinland pension (deutsche Rentenversicherung Rheinland)

- Sufficient language skills

- Age 18-58

Exclusion Criteria:

- Acute cardiac decompensation

- consuming the underlying disease

- psychotic disorder

- Acute suicidality

- pregnancy

Study Design

Allocation: Randomized, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Treatment


Intervention

Other:
interval-rehabilitation
The Patients in the intervention group receive a Stationary psychocardiological interval-rehabilitation.The Interval rehabilitation is divided into individual psychological therapy with focus of Behavior therapy and relaxation therapy.

Locations

Country Name City State
Germany Clinic Roderbirken Leichlingen NRW

Sponsors (1)

Lead Sponsor Collaborator
Clinic Roderbirken

Country where clinical trial is conducted

Germany, 

Outcome

Type Measure Description Time frame Safety issue
Primary Improvement of the social medical progression of coronary heart disease with associated psychosocial comorbidity by the use of interval rehabilitaion Reducing the rate of disability pension of 18%of 9% by interval-rehabilitation with aftercare. 24 months after including study No
Secondary Improvement of the social medical progression of coronary heart disease with associated psychosocial comorbidity by the use of interval rehabilitaion Reduction of cardiovascular events, including deaths Improving the risk profile Improvement of health-related quality of life Improvement of mental comorbidity 24 months after including study No
See also
  Status Clinical Trial Phase
Completed NCT03798457 - Incidence and Prognostic Implication of Acute CV Events in Patients Hospitalized for CAP in Internal Medicine Units.
Completed NCT01223586 - Extended Japan Assessment of Pitavastatin and Atorvastatin in Acute Coronary Syndrome N/A
Recruiting NCT05985447 - Menopause Related Influences on Leukocyte Distribution, Monocyte Function and Platelet Reactivity
Recruiting NCT05457582 - PCSK 9 Inhibitor Added to High-Intensity Statin Therapy to Prevent Cardiovascular Events in Patients With ACS After PCI N/A
Completed NCT01755078 - Long Term Evaluation of Sevelamer HCl vs. Calcium-based Phosphate Binder in the Treatment of Hyperphosphatemia in Hemodialysis Patients Phase 4
Recruiting NCT04183426 - Tonometry(1) and Duplex Ultrasound(2) to Predict CV Events in to be Treated Patients With an AAA
Recruiting NCT03154203 - Non-Invasive Aortic Ambulatory Blood Pressure Monitoring for The Detection of Target Organ Damage in The Chinese Population N/A
Completed NCT03989011 - Tonometry and Duplex Ultrasound to Predict AAA Progression and CV Events in Aneurysm Patients (1-2-3 Trial)
Terminated NCT01259297 - A Randomized Controlled Trial of Aliskiren in the Prevention of Major Cardiovascular Events in Elderly People Phase 3
Completed NCT01395550 - Secondary Prevention Treatment in Patients Who Have Suffered a Cardiovascular Event N/A
Completed NCT03391128 - Circulating P3NP and Cardiovascular Events in Hemodialysis Patients N/A
Completed NCT04776226 - Post-stroke Depression Treatment Effect on Stroke Recurrence N/A
Recruiting NCT06029933 - Fluad vs. Fluzone High-Dose Vaccine Effectiveness Among Adults ≥65 Years
Active, not recruiting NCT05220917 - Comparative Effectiveness and Safety of Four Second Line Pharmacological Strategies in Type 2 Diabetes Study
Active, not recruiting NCT05063097 - Addiction in Intensive Cardiac Care Units
Not yet recruiting NCT06333574 - Weight Management of Dialysis Patients N/A